Companies/US/EPRX

EUPRAXIA PHARMACEUTICALS INC.

Last · NASDAQ$6.59-0.09 (-1.35%)close · yahoo · 11h ago
Vol 278.2K ≈ 1.83M
Market cap$435.42M66.1M sh
P/E · TTM-6.6fwd -6.4 · eps -1.00 · loss
Beta1.22vs S&P 500
Div yield0.00%annual · TTM
52w range
$5.25$9.32
Volume278.2Ksession

Issuer

Legal nameEUPRAXIA PHARMACEUTICALS INC.
HQUnited States (US)
ListingUS EPRX
ISINCA29842P1053
LEI254900ABKL5YBZMSYH45
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrylei:254900ABKL5YBZMSYH45
Org IDEPRX
CIK0001581178
Websitewww.eupraxiapharma.com
Employees49
AddressEupraxia Pharmaceuticals, Inc. 2067 Cadboro Bay Road V8R 5G4, Victoria +250 590 3968
Loading chart…

Upcoming earnings

1 event
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.26
Est. revenue
0
View upcoming earnings →

Press & signals

2 recent
  • GlobeNewswire

    Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results

  • GlobeNewswire

    Eupraxia Pharmaceuticals Strengthens Executive Leadership Team to Support Next Phase of Growth

Documents

FormReporting forFiledFlags
6-K
—2026-10-090
6-K
—2026-09-080
6-K
—2026-08-130
6-K
—2026-08-110
6-K
—2026-07-150
Showing 5 of 65 filings